2 reports

  • 18.1 Competitive Scenario
  • 18.2 Market Share Analysis 2014

Introduction Glioblastoma multiforme is a variant of brain cancer, and is one of the most aggressive diseases.

  • Cancer
  • United States
  • World
  • Market Size
  • Arbor Pharmaceuticals, LLC
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2018
  • Toll Like Receptor 8 (CD288 or TLR8) - Therapeutics Development

In this trial, ## patients with PASI scores of ##. ## or greater will be randomized ##:##:##:## to receive weekly subcutaneous doses of IMO-## at ##. ##, ##. ##, or ##. ## mg/ kg/ week or placebo for ## weeks.

  • Cancer
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Idera Pharmaceuticals, Inc.